Approaches to the Development and Use of PRO Measures: A New Roadmap

Paul Kamudoni, Nutjaree Johns, Mir-Saeed Shayegan Salek

Research output: Chapter in Book/Report/Conference proceedingChapter


Various recent developments are driving an evolution in the way PRO measures are developed. For example, drug regulatory agencies (e.g. the FDA) can now be more substantively involved or consulted on measure development work; the patients’ role is now seen as going beyond being a study subject to being involved as research partners. Use of modern test theory in development of scoring algorithms and overall measure development work is now the new ‘gold standard’.
Original languageEnglish
Title of host publicationLiving with Chronic Disease: Measuring Important Patient-Reported Outcomes
Place of PublicationSingapore
Number of pages34
ISBN (Electronic)978-981-10-8414-0
ISBN (Print)978-981-10-8413-3
Publication statusPublished - 7 Sept 2018


Dive into the research topics of 'Approaches to the Development and Use of PRO Measures: A New Roadmap'. Together they form a unique fingerprint.

Cite this